Scimago Journal & Country Rank
menu
| Title | Type |  SJR |
H index | Total Docs. (2018) | Total Docs. (3years) | Total Refs. (2018) | Total Cites (3years) | Citable Docs. (3years) | Cites / Doc. (2years) | Ref. / Doc. (2018) | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Nature Reviews Drug Discovery | journal | 9.483 Q1 | 391 | 255 | 680 | 8914 | 6743 | 350 | 9.02 | 34.96 |  |
| 2 | Trends in Pharmacological Sciences | journal | 4.586 Q1 | 244 | 93 | 284 | 7123 | 3018 | 250 | 9.24 | 76.59 | |
| 3 | Journal for ImmunoTherapy of Cancer | journal | 3.337 Q1 | 117 | 150 | 269 | 6491 | 1982 | 241 | 8.01 | 43.27 | |
| 4 | Neuropsychopharmacology | journal | 3.205 Q1 | 249 | 318 | 906 | 16743 | 5824 | 836 | 6.47 | 52.65 | |
| 5 | npj Vaccines | journal | 2.527 Q1 | 47 | 51 | 50 | 2652 | 236 | 48 | 4.72 | 52.00 | |
| 6 | Drug Discovery Today | journal | 2.248 Q1 | 215 | 215 | 576 | 15826 | 4269 | 545 | 7.04 | 73.61 | |
| 7 | Journal of Antimicrobial Chemotherapy | journal | 2.139 Q1 | 221 | 569 | 1517 | 18751 | 6676 | 1291 | 4.38 | 32.95 | |
| 8 | PharmacoEconomics | journal | 1.942 Q1 | 118 | 121 | 332 | 4808 | 1253 | 285 | 3.17 | 39.74 | |
| 9 | International Journal of Neuropsychopharmacology | journal | 1.846 Q1 | 125 | 138 | 406 | 7958 | 1857 | 395 | 4.21 | 57.67 | |
| 10 | Neuropharmacology | journal | 1.780 Q1 | 191 | 500 | 1254 | 37062 | 5581 | 1232 | 4.41 | 74.12 | |
| 11 | Journal of Psychopharmacology | journal | 1.672 Q1 | 135 | 138 | 426 | 8170 | 1978 | 401 | 4.03 | 59.20 | |
| 12 | Expert Review of Vaccines | journal | 1.603 Q1 | 105 | 102 | 358 | 8283 | 1412 | 327 | 4.12 | 81.21 | |
| 13 | BioDrugs | journal | 1.601 Q1 | 79 | 60 | 128 | 3632 | 663 | 124 | 5.11 | 60.53 | |
| 14 | British Journal of Clinical Pharmacology | journal | 1.530 Q1 | 167 | 315 | 866 | 11637 | 3241 | 741 | 3.51 | 36.94 | |
| 15 | Clinical Pharmacokinetics | journal | 1.529 Q1 | 184 | 119 | 340 | 6974 | 1545 | 311 | 4.47 | 58.61 | |
| 16 | Therapeutic Advances in Neurological Disorders | journal | 1.521 Q1 | 68 | 80 | 111 | 4715 | 476 | 102 | 3.89 | 58.94 | |
| 17 | Expert Opinion on Therapeutic Targets | journal | 1.470 Q1 | 106 | 91 | 359 | 9798 | 1568 | 333 | 4.30 | 107.67 | |
| 18 | Drug Safety | journal | 1.438 Q1 | 140 | 132 | 324 | 4868 | 1211 | 273 | 3.30 | 36.88 | |
| 19 | Clinical Trials | journal | 1.417 Q1 | 74 | 80 | 275 | 2302 | 528 | 219 | 1.88 | 28.78 | |
| 20 | Acta Pharmacologica Sinica | journal | 1.224 Q1 | 117 | 189 | 460 | 10647 | 1838 | 454 | 3.81 | 56.33 | |
| 21 | Expert Opinion on Biological Therapy | journal | 1.133 Q1 | 102 | 154 | 460 | 11044 | 1661 | 435 | 3.58 | 71.71 | |
| 22 | CNS Neuroscience and Therapeutics | journal | 1.122 Q1 | 91 | 137 | 352 | 7603 | 1071 | 290 | 3.00 | 55.50 | |
| 23 | Pharmacogenomics Journal | journal | 1.096 Q1 | 95 | 93 | 230 | 4259 | 833 | 226 | 3.42 | 45.80 | |
| 24 | Expert Opinion on Investigational Drugs | journal | 1.076 Q1 | 117 | 94 | 395 | 7440 | 1303 | 376 | 3.61 | 79.15 | |
| 25 | Molecular Diagnosis and Therapy | journal | 1.069 Q1 | 68 | 62 | 168 | 4756 | 486 | 163 | 3.16 | 76.71 | |
| 26 | Expert Opinion on Therapeutic Patents | journal | 1.018 Q1 | 88 | 78 | 326 | 6056 | 1139 | 320 | 3.76 | 77.64 | |
| 27 | Expert Opinion on Emerging Drugs | journal | 0.977 Q2 | 54 | 29 | 116 | 2879 | 361 | 108 | 3.05 | 99.28 | |
| 28 | Antiviral Therapy | journal | 0.931 Q2 | 93 | 94 | 293 | 2958 | 586 | 285 | 2.03 | 31.47 | |
| 29 | Drugs in Context | journal | 0.921 Q2 | 36 | 46 | 43 | 3211 | 126 | 41 | 1.04 | 69.80 | |
| 30 | Future Medicinal Chemistry | journal | 0.916 Q2 | 90 | 216 | 506 | 11624 | 1557 | 447 | 2.87 | 53.81 | |
| 31 | Expert Opinion on Drug Metabolism and Toxicology | journal | 0.896 Q2 | 100 | 116 | 405 | 10206 | 1345 | 380 | 3.42 | 87.98 | |
| 32 | Phytotherapy Research | journal | 0.884 Q2 | 158 | 244 | 663 | 13848 | 2548 | 661 | 4.07 | 56.75 | |
| 33 | ChemMedChem | journal | 0.880 Q2 | 119 | 273 | 763 | 13459 | 1985 | 737 | 2.73 | 49.30 | |
| 34 | Journal of Cardiovascular Pharmacology and Therapeutics | journal | 0.877 Q2 | 57 | 59 | 183 | 2788 | 424 | 176 | 2.33 | 47.25 | |
| 35 | BMC pharmacology & toxicology | journal | 0.870 Q2 | 43 | 87 | 185 | 3087 | 467 | 184 | 2.32 | 35.48 | |
| 36 | Pharmaceutical Statistics | journal | 0.868 Q2 | 46 | 64 | 151 | 1793 | 187 | 146 | 1.45 | 28.02 | |
| 37 | Expert Opinion on Pharmacotherapy | journal | 0.866 Q2 | 93 | 213 | 696 | 15010 | 2012 | 652 | 2.80 | 70.47 | |
| 38 | Drugs in R and D | journal | 0.833 Q2 | 54 | 35 | 135 | 1089 | 371 | 128 | 2.40 | 31.11 | |
| 39 | Journal of Enzyme Inhibition and Medicinal Chemistry | journal | 0.781 Q2 | 92 | 161 | 595 | 7720 | 2400 | 595 | 4.36 | 47.95 | |
| 40 | Cardiovascular Therapeutics | journal | 0.780 Q2 | 54 | 63 | 179 | 2156 | 407 | 176 | 2.22 | 34.22 | |
| 41 | Pharmacogenomics | journal | 0.768 Q2 | 100 | 136 | 514 | 7014 | 1240 | 499 | 2.21 | 51.57 | |
| 42 | Clinical and Experimental Pharmacology and Physiology | journal | 0.717 Q2 | 115 | 161 | 477 | 6525 | 1030 | 448 | 2.16 | 40.53 | |
| 43 | Fundamental and Clinical Pharmacology | journal | 0.712 Q2 | 85 | 72 | 197 | 3009 | 464 | 196 | 2.20 | 41.79 | |
| 44 | Journal of Clinical Pharmacy and Therapeutics | journal | 0.710 Q2 | 81 | 146 | 375 | 4025 | 813 | 359 | 2.24 | 27.57 | |
| 45 | MedChemComm | journal | 0.673 Q2 | 0 | 0 | 0 | 0 | 0 | 0 | 0.00 | 0.00 | |
| 46 | Journal of Antibiotics | journal | 0.666 Q2 | 92 | 146 | 468 | 4947 | 1038 | 427 | 2.29 | 33.88 | |
| 47 | Journal of Peptide Science | journal | 0.662 Q2 | 73 | 65 | 299 | 2659 | 593 | 292 | 2.04 | 40.91 | |
| 48 | DARU, Journal of Pharmaceutical Sciences | journal | 0.658 Q2 | 58 | 24 | 104 | 897 | 337 | 98 | 2.63 | 37.38 | |
| 49 | Pharmaceutical Biology | journal | 0.625 Q2 | 88 | 81 | 923 | 3712 | 2323 | 922 | 2.59 | 45.83 | |
| 50 | Chemical Biology and Drug Design | journal | 0.597 Q2 | 91 | 199 | 623 | 7588 | 1484 | 590 | 2.26 | 38.13 | |
Powered by:
Follow us on @ScimagoJR
Scimago Lab, Copyright 2007-2024. Data Source: Scopus®
Download data